0001209191-18-037845.txt : 20180614 0001209191-18-037845.hdr.sgml : 20180614 20180614181449 ACCESSION NUMBER: 0001209191-18-037845 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20180614 FILED AS OF DATE: 20180614 DATE AS OF CHANGE: 20180614 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: EDWARDS MARK G CENTRAL INDEX KEY: 0001190429 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-35068 FILM NUMBER: 18900286 MAIL ADDRESS: STREET 1: ALLOS THERAPEUTICS, INC. STREET 2: 11080 CIRCLEPOINT ROAD, SUITE 200 CITY: WESTMINSTER STATE: CO ZIP: 80020 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ACELRX PHARMACEUTICALS INC CENTRAL INDEX KEY: 0001427925 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 BUSINESS PHONE: 650-216-3500 MAIL ADDRESS: STREET 1: 351 GALVESTON DRIVE CITY: REDWOOD CITY STATE: CA ZIP: 94063 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2018-06-14 0 0001427925 ACELRX PHARMACEUTICALS INC ACRX 0001190429 EDWARDS MARK G C/O ACELRX PHARMACEUTICALS, INC. 351 GALVESTON DRIVE REDWOOD CITY CA 94063 1 0 0 0 Stock Options (Right to Buy) 4.125 2018-06-14 4 A 0 15000 0.00 A 2018-07-14 2028-06-14 Common Stock 15000 15000 D The shares subject to the option vest as follows: 1/24th of the shares subject to the option vest in equal monthly installments over 24 months, subject to Optionee's Continuous Service to the Company. 100% Acceleration upon Change of Control. /s/ Martha Adler, Attorney-In-Fact 2018-06-14